Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Congressional Appropriators Encourage FDA Guidance On Contraceptive OTC Switches

Jul 14 2024

• By Malcolm Spicer

• Source: Shutterstock

Related Content

US FDA Has 10 Months To Provide Answer On Perrigo/HRA OTC Oral Contraceptive Application

Jul 12 2022

US Revamped OTC Monograph Program Changes Start With Acetaminophen Skin Reaction Warning

Jun 17 2024

US FDA Requests More Information, Needs More Time To Review Birth Control OTC Switch Proposal

Oct 27 2022

No Change To US FDA’s Risk-Based Homeopathic Enforcement From Its OTC Monograph Overhaul

Dec 08 2022

In Proposed Appropriation, Congress Tells FDA To Repurpose $7M For Cosmetic Regulation

Mar 05 2024

House Appropriators Develop Hazy Picture For Future Of US Hemp Products Industry

Jul 11 2024

FDA Request For Help On Hemp Regulation Gets Lower Profile In House Appropriators' Report

Jul 11 2024

PETA Challenges FDA 'Insistence' On Animal Testing For Sunscreen Products

Jul 11 2024

OTC Diagnostics Forecast: Growing With Pandemic But High Bar For Approval Could Slow Spread

Dec 13 2020

US FDA’s Sunscreen Proposal Rattles International Trade, And What About Public Health?

Dec 14 2021

Premarket Review Approval For COVID-19 Test Is US FDA's First For OTC Respiratory Diagnostic

Jun 06 2023

Cloud Over FDA Advisory Panel Meeting From ‘Over-Reporting’ In Birth Control OTC Switch Study

May 10 2023

Related Companies

Perrigo Company PLC

Additional Topics

International United States FDA Prescription To OTC Switch Women's Health Commercial Compliance Consumer Dietary Supplements Drug Review Drug Approval Standards Ingredients Manufacturing OTC Drugs Policy Politics Regulation Retail

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window